PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma - PubMed (original) (raw)

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma

Sam C Brownhill et al. Pract Lab Med. 2016.

Abstract

Metastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent growth of tumour cells at distant sites being the cause of most cancer deaths. Molecular characterization and detection of the tumour cells responsible for haematogenous spread may increase understanding of the biology of metastasis, help improve patient management and allow evaluation of novel treatments to prevent and eradicate this disease. The bone marrow is a common site to which tumour cells metastasize, from which they may re-circulate to other organs with a favourable microenvironment for growth. The detection of tumour cells in blood suggests one route for metastasis, and provides an accessible, minimally invasive liquid sample through which it may be possible to monitor and detect minimal disease and early signs of metastasis. Significant improvements in the sensitivity and specificity of tumour cell detection have been made, such that it is now possible to unambiguously detect a single tumour cell in over 10 million normal cells. However, the clinical impact of such low level disease and how to interpret the natural variation that can arise from sequential sampling of bone marrow aspirates and blood is currently largely unknown. This commentary will focus on the technical advancements and application of reverse transcriptase polymerase chain reaction to detect cancer mRNAs in bone marrow and blood, and discuss the potential clinical impact of this test in neuroblastoma.

Keywords: Blood; Bone marrow; Circulating; Disseminating; Neuroblastoma; RTqPCR; Tumour cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kawasaki E.S., Clark S.S., Coyne M.Y., Smith S.D., Champlin R., Witte O.N., McCormick F.P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. USA. 1988;85(15):5698–5702. - PMC - PubMed
    1. Roth M.S., Antin J.H., Ash R., Terry V.H., Gotlieb M., Silver S.M., Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood. 1992;79(1):276–282. - PubMed
    1. Peter M., Magdelenat H., Michon J., Melot T., Oberlin O., Zucker J.M. Sensitive detection of occult ewing’s cells by the reverse transcriptase-polymerase chain reaction. Br. J. Cancer. 1995;72(1):96–100. - PMC - PubMed
    1. West D.C., Grier H.E., Swallow M.M., Demetri G.D., Granowetter L., Sklar J. Detection of circulating tumor cells in patients with Ewing’s sarcoma and peripheral primitive neuroectodermal tumor. J. Clin. Oncol. 1997;15(2):583–588. - PubMed
    1. de Alava E., Lozano M.D., Patiño A., Sierrasesúmaga L., Pardo-Mindán F.J. Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples. Diagn. Mol. Pathol. 1998;7(3):152–157. - PubMed

LinkOut - more resources